Welcome to our dedicated page for Fabrinet SEC filings (Ticker: FN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Fabrinet (NYSE: FN) SEC filings page brings together the company’s official U.S. Securities and Exchange Commission disclosures, offering investors a structured view of its regulatory record. As a Cayman Islands–incorporated issuer with operations in Thailand, the United States, the People’s Republic of China, and Israel, Fabrinet files detailed reports that explain its financial performance, governance practices, and executive compensation programs.
Through its annual reports on Form 10-K, Fabrinet presents audited financial statements, management’s discussion and analysis, and risk factor disclosures. These documents describe revenue trends across markets such as optical communications, automotive components, industrial lasers, medical devices, and sensors, as well as information on gross margins, operating margins, cash flows, and capital investments in manufacturing facilities and equipment.
Quarterly updates, often furnished via Form 8-K with attached earnings press releases, provide interim financial results and commentary from management. Fabrinet also uses Form 8-K to report material events such as leadership changes, board appointments and retirements, and the adoption of executive incentive plans and equity awards.
The company’s definitive proxy statement on Schedule 14A offers additional insight into corporate governance, including board structure, ESG practices and policies, director and executive compensation, and matters presented for shareholder vote at the Annual General Meeting. It details items such as the election of directors, ratification of the independent auditor, and advisory votes on named executive officer compensation.
On Stock Titan, Fabrinet’s filings are updated in near real time from the SEC’s EDGAR system. AI-powered summaries help explain lengthy documents like the 10-K and proxy statement by highlighting key metrics, governance decisions, compensation structures, and risk discussions. Investors can also review Form 4 and other ownership-related filings to monitor insider transactions and equity awards, using the platform’s tools to quickly understand how these regulatory disclosures relate to Fabrinet’s broader financial and operational profile.
Fabrinet (FN) insider sale reported by Csaba Sverha, Chief Financial Officer. The Form 4 shows two sales on 08/28/2025: 7,981 ordinary shares sold at a weighted average price of $349.594 (range $349.01–$349.95) and 5,019 ordinary shares sold at a weighted average price of $350.275 (range $350.02–$350.73). The filing lists post-transaction beneficial ownership figures of 13,571 and 8,552 shares respectively. The Form 4 was submitted by Andrew Chew as attorney-in-fact on 08/29/2025. Explanations note the reported prices are weighted averages and that the reporting person will provide detailed per-price sale counts upon request.
Fabrinet (FN) insider Seamus Grady, who serves as Chief Executive Officer and a director, reported multiple open-market sales of ordinary shares on 08/27/2025. The Form 4 shows five separate sale transactions totaling 9,513 shares at weighted-average prices ranging from about $328 to $333.12 per share. The filings list the reporter's beneficial ownership declining from 52,024 shares before the series of sales to 46,024 shares after the last reported sale.
The filings were signed by an attorney-in-fact on 08/29/2025 and include weighted-average price ranges for several tranches; no derivative transactions or other changes were reported.
Fabrinet director Darlene S. Knight reported a sale of 1,200 ordinary shares on 08/27/2025 at a weighted-average price of $335.125 per share (range $335.04–$335.35). After the sale, she beneficially owns 4,163 shares, held directly. The Form 4 was signed by an attorney-in-fact and indicates the filing is by one reporting person.
This filing discloses a routine insider disposition rather than an acquisition or derivative transaction. The report provides the exact sale quantity, the weighted-average price, and the resulting direct ownership stake, but does not state any planned future transactions or reasons for the sale.
Fabrinet (FN) Form 144 notice: The filer reports a proposed sale of 3,200 ordinary shares through Citigroup Global Markets, Inc. on the NYSE with an aggregate market value of $1,069,440.00 and an approximate sale date of 08/29/2025. The shares were acquired on 08/29/2025 by vesting from a share account and were received as compensation. The filing indicates no securities sold by the reporting person in the past three months and includes the required representation that the seller is unaware of undisclosed material adverse information about the issuer.
Filer submitted a Form 144 reporting proposed sales of 13,000 ordinary shares of Fabrinet (FN) through Citigroup Global Markets, with an aggregate market value of $4,568,200.00 and an approximate sale date of 08/28/2025. The filing states these shares were acquired on 08/28/2025 via restricted stock vesting from Fabrinet and were issued as payment for services rendered. The filing also discloses a prior sale by the same account of 10,000 shares on 08/25/2025 generating $3,106,786.92 in gross proceeds. The filer certifies they possess no undisclosed material adverse information.
Form 144 notice for Fabrinet (FN) indicates a proposed sale of 9,513 ordinary shares through Bay Crest Partners on the NYSE with an aggregate market value of 3,145,569 and approximately 35,729,581 shares outstanding. The shares to be sold were acquired by the selling person as vested RSU and PSU grants on 08/19/2023 (2,599 shares), 08/20/2023 (4,392 shares) and 08/24/2024 (2,522 shares), matching the total offered for sale.
The notice reports no securities sold by the same person in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer. The form identifies the broker, planned approximate sale date of 08/27/2025, and nature of payment as vesting of equity awards.
Fabrinet (FN) submitted a Rule 144 notice reporting a proposed sale of 1,200 ordinary shares through Citigroup Global Markets, valued at $402,150, with an approximate sale date of 08/27/2025 on the NYSE. The filer acquired the shares on 01/02/2024 by restricted stock vesting from Fabrinet and lists the payment nature as services rendered.
The filing shows there were 35,728,074 shares outstanding, so the 1,200-share sale represents a very small fraction of the company. No other securities were reported sold in the past three months, and the notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Csaba Sverha, Chief Financial Officer of Fabrinet (FN), reported insider transactions reducing his holdings. Restricted share units were withheld for taxes in two transactions on 08/22/2025 and 08/24/2025 (217 and 321 shares). On 08/25/2025 the reporting person sold a total of 10,000 ordinary shares in three trades at weighted-average prices of approximately $309.88, $310.96, and $311.70. Following these transactions the filing shows 21,552 shares beneficially owned. The Form 4 includes explanations that the withheld shares covered tax liabilities related to RSU vesting and provides weighted-average price ranges for the sales.
Seamus Grady, who is identified as both Director and Chief Executive Officer of Fabrinet (FN), reported two routine sales of company stock to satisfy tax obligations tied to vested restricted share units. On 08/22/2025 he disposed of 1,817 ordinary shares at $294.35 per share, leaving 58,474 shares beneficially owned. On 08/24/2025 he disposed of 2,937 shares at the same price, leaving 55,537 shares. The filing states these shares were withheld to cover the reporting person’s tax liability related to RSU vesting. The form was signed by an attorney-in-fact, Andrew Chew, on 08/26/2025.
Harpal Gill, President & COO and Director of Fabrinet (FN), reported disposition of shares withheld to cover taxes on vested restricted share units. The Form 4 shows two withholding events: 1,165 shares were surrendered on 08/22/2025 and 1,836 shares on 08/24/2025, both at a price of $294.35 per share. Following the transactions the reporting person’s direct beneficial ownership declined from 30,022 shares to 28,186 shares. The filing identifies the dispositions as tax-withholding for RSU vesting rather than open-market sales.